Daniel A. Casciano, Ph.D. is the Director of the Food and Drug Administration’s National Center for Toxicological Research. His primary research interests include development of in vitro and in vivo transgenic mutational and carcinogenic systems to better extrapolate toxicological endpoints to the human condition and encourage the utlitzation of DNA microarray, proteomic and bioinformatic technology to important questions in Toxicology.
Delongchamp, R.R., C. Velasco-Gonzalez, R. Evans, A.J. Harris and D.A. Casciano. A median estimate that adjusts cDNA array data for nuisance effects, J. Biol. Systems, 2001.
McClain, R.M., D. Keller, D. Casciano, J. Macdonald, J. Popp and J. Sagartz. Neonatal mouse assay: Overview of available data, J. Tox. Path, 2001. 29: 128-137.
Morris, S.M., W.G. Hinson, J.G. Shaddock, W.H. Tolleson, J.L. Pipkin and D.A. Casciano, Decreased in vitro interaction between p53 and nuclear stress proteins in the p53 deficient mouse, Electrophoresis, 2001. 22: 2092-2097.
